Copyright
©The Author(s) 2025.
World J Gastrointest Oncol. Feb 15, 2025; 17(2): 100546
Published online Feb 15, 2025. doi: 10.4251/wjgo.v17.i2.100546
Published online Feb 15, 2025. doi: 10.4251/wjgo.v17.i2.100546
Table 2 Recent findings of the experimental studies in gastrointestinal cancers related to protein tyrosine phosphatase nonreceptor 2
Ref. | Organ | Methods | Findings related to PPTN2 |
Spalinger et al[14] | Colon | CC, IF | PPTN2 dysfunction in T cells drives the secretion of IFN-γ and IL-17. PPTN2 dysfunction promotes IL-18, IL-1β secretion and increased inflammasome assembly. Protects from CRC development |
Manguso et al[15] | Colon | AE | Loss of PTPN2 enhances Tim-3+ CD8+ T cell differentiation promoting anti-tumor immunity |
Tang et al[1] | Colon | TCGA, GTEx data analysis | Positive correlation with CD8+ cells. Knockdown inhibits proliferation of cancer cells and leads to abundance of PD-L1 |
Huang et al[26] | Pancreas | CC, WB | Silencing PTPN2 attenuates the proliferation of cancer cells. PTPN2 regulates the level of tyrosine phosphorylation of KRAS. PTPN2 knockdown was consistent with that of knockdown of KRAS |
Kuang et al[25] | Pancreas | TCGA, GTEx data analysis | PTPN2 mRNA expression upregulated and related to JAK-STAT pathway. Down-regulation diminishes tumor burden |
Zhang et al[18] | Pancreas | Human tumor tissue, IHC, RT-PCR, IF, WB, CC, AE | Knockdown promotes the migration and invasion abilities. PTPN2 inhibited metastasis, and presented a novel PTPN2/p-STAT3/MMP-1 axis in progression |
Grohmann et al[28] | HCC | AE | PTPN2 deletion in hepatocytes promoted T cell recruitment. PTPN2 deletion promotes STAT-3 dependent HCC |
Tang et al[1] | HCC | TCGA, GTEx data analysis | Terminal differentiation-induced lncRNA preserved STAT3 phosphorylation via direct interacting with PTPN2. The activation of STAT3 downstream target genes and promote HCC cell growth, migration, and infiltration |
- Citation: Gunizi OC, Elpek GO. Protein tyrosine phosphatase nonreceptor 2: A New biomarker for digestive tract cancers. World J Gastrointest Oncol 2025; 17(2): 100546
- URL: https://www.wjgnet.com/1948-5204/full/v17/i2/100546.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v17.i2.100546